Edesa Biotech, Inc. SEC filings EDSA
Edesa Biotech, Inc. has 751 filings in SEC EDGAR's recent list, going back to Feb 3, 2012. Its latest annual report, Form ARS, was filed on Apr 3, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (officer or director change). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 3, 2026 | Sep 30, 2025 |
| 10-K | Annual report | Dec 12, 2025 | Sep 30, 2025 |
| ARS | Annual report to shareholders | Apr 4, 2025 | Sep 30, 2024 |
| 10-K/A | Amended annual report | Dec 20, 2024 | Sep 30, 2024 |
| 10-K | Annual report | Dec 13, 2024 | Sep 30, 2024 |
| ARS | Annual report to shareholders | Apr 5, 2024 | Sep 30, 2023 |
| 10-K | Annual report | Dec 15, 2023 | Sep 30, 2023 |
| ARS | Annual report to shareholders | Apr 7, 2023 | Sep 20, 2022 |
| 10-K/A | Amended annual report | Mar 27, 2023 | Sep 30, 2022 |
| 10-K | Annual report | Dec 16, 2022 | Sep 30, 2022 |
| 10-K | Annual report | Dec 28, 2021 | Sep 30, 2021 |
| 10-K | Annual report | Dec 7, 2020 | Sep 30, 2020 |
| 10-KT | Transition report | Dec 12, 2019 | Sep 30, 2019 |
| 10-K | Annual report | Nov 30, 2018 | Sep 30, 2018 |
| 10-K | Annual report | Dec 1, 2017 | Sep 30, 2017 |
| 10-K | Annual report | Dec 14, 2016 | Sep 30, 2016 |
| 10-K | Annual report | Dec 14, 2015 | Sep 30, 2015 |
| 10-K/A | Amended annual report | Sep 9, 2015 | Aug 31, 2014 |
| ARS | Annual report to shareholders | Jan 20, 2015 | Dec 31, 2014 |
| 10-K/A | Amended annual report | Nov 21, 2014 | Aug 31, 2014 |
| 10-K | Annual report | Nov 14, 2014 | Aug 31, 2014 |
| 20-F | Annual report (foreign issuer) | Dec 31, 2013 | Aug 31, 2013 |
| 20-F | Annual report (foreign issuer) | Jan 15, 2013 | Aug 31, 2012 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EDSA (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- British Columbia, Canada
- Headquarters
- Toronto
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1540159
- Former names
- Stellar Biotechnologies, Inc. (until May 30, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.